开发GluN2ANMDA受体阳性全调节剂:最近的进展和前景
Ping Li1, Jiacheng Wang1, Mengjiao Wang1
1Department of Medicinal Chemistry, School of Pharmacy, Qingdao University, Qingdao 266021, China.
Bioorganic & medicinal chemistry
|April 16, 2025
概括
针对N-甲基-D-酸盐 (NMDA) 受体,特别是GluN2A亚型的阳性全调节剂 (PAMs) 对治疗精神疾病有希望. 这些化合物为阿尔茨海默氏症和抑郁症等疾病提供了新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- N-甲基-D-酸盐 (NMDA) 受体对于中枢神经系统 (CNS) 中的突触传播和可塑性至关重要.
- 在NMDA受体中,从GluN2B向GluN2A亚单元表达发生发育转变.
- NMDA受体的功能下降与精神疾病有关.
研究的目的:
- 审查针对NMDA受体GluN2A亚单元的选择性正调节剂 (PAMs).
- 讨论这些PAM在神经精神疾病中的治疗潜力.
主要方法:
- 专注于针对GluN2A.的联结域 (LBD) 和N终端域 (NTD) 的PAMs.
- 包括非子单位的选择性PAMs.
主要成果:
- 激活含有GluN2A的NMDA受体是一种有前途的治疗策略.
- 选择性PAM提供了针对性的NMDA受体功能的调节.
结论:
- 用PAMs准含有GluN2A的NMDA受体,有可能治疗中风,抑郁症,阿尔茨海默氏症和亨廷顿病.
- 对这些PAM的进一步研究可能会导致新的神经精神病治疗方法.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
85
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
85
Ligand-gated Ion Channels
12.0K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.0K
Antiepileptic Drugs: Glutamate Antagonists
250
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
250
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
Drugs Acting on Autonomic Ganglia: Stimulants
1.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.2K


